Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

Cited by (1,006)

Items 301–400 of 1,006

1. Protein tyrosine kinases and cancer
   Kathryn S. Kolibaba, Brian J. Druker · 1997 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
2. YKL-40, a secreted glycoprotein, promotes tumor angiogenesis
   Rong Shao, Katie M. Hamel, Louise Munkhaus Petersen, Q J Cao, Richard B. Arenas, Carol Bigelow, Brook A. Bentley, Wei Yan · 2009 · Oncogene
3. The mechanism of cancer-mediated conversion of plasminogen to the angiogenesis inhibitor angiostatin
   Stephen Thomas Gately, Przemyslaw W. Twardowski, Mary Sharon Stack, Deborah L. Cundiff, Davida K. Grella, Francis Castellino, Jan J. Enghild, Hau C. Kwaan, Francis Y. Lee, Robert A. Kramer et al. · 1997 · Proceedings of the National Academy of Sciences
4. The Delta paradox: DLL4 blockade leads to more tumour vessels but less tumour growth
   Gavin Thurston, Irene Noguera‐Troise, George D. Yancopoulos · 2007 · Nature reviews. Cancer
5. The impact of VEGF on cancer metastasis and systemic disease
   Yunlong Yang, Yihai Cao · 2022 · Seminars in Cancer Biology
6. Different angiogenic pathways characterize superficial and invasive bladder cancer.
   Tim O’Brien, David Cranston, S Fuggle, Roy Bicknell, Adrian Llewellyn Harris · 1995 · PubMed
7. Metronomic Cyclophosphamide and Capecitabine Combined With Bevacizumab in Advanced Breast Cancer
   Silvia Dellapasqua, Francesco Bertolini, Vincenzo Bagnardi, Elisabetta Campagnoli, Eloise Scarano, Rosalba Torrisi, Yuval Shaked, Patrizia Mancuso, Aron Goldhirsch, Andrea Rocca et al. · 2008 · Journal of Clinical Oncology
8. Function of fibroblast growth factors and vascular endothelial growth factors and their receptors in angiogenesis
   Pär Gerwins, Erik G. Sköldenberg, Lena Claesson · 2000 · Critical Reviews in Oncology/Hematology
9. The PTEN/PI3K pathway governs normal vascular development and tumor angiogenesis
   Koichi Hamada, Takehiko Sasaki, Pandelakis A. Koni, Miyuki Natsui, Hiroyuki Kishimoto, Junko Sasaki, Nobuyuki Yajima, Yasuo Horie, Go Hasegawa, Makoto Naito et al. · 2005 · Genes & Development
10. Cytokine regulation of angiogenesis in breast cancer: the role of tumor-associated macrophages
    Claire E. Lewis, Russell Leek, Adrian Llewellyn Harris, J O McGee · 1995 · Journal of Leukocyte Biology
11. Implication of Tumor Microenvironment in Chemoresistance: Tumor-Associated Stromal Cells Protect Tumor Cells from Cell Death
    Magali Castells, Benoît Thibault, Jean‐Pierre Delord, Bettina C. Couderc · 2012 · International Journal of Molecular Sciences
12. Mechanisms of retinal and choroidal neovascularization.
    Patrìcia A. D'Amore · 1994 · PubMed
13. Nuclease-resistant nucleic acid ligands to vascular permeability factor/vascular endothelial growth factor
    Louis S. Green, Derek Jellinek, Carol Bell, Laurie A. Beebe, Bruce D. Feistner, Stanley C. Gill, Fiona M. Jucker, Nebojša Janjić · 1995 · Chemistry & Biology
14. Matrix metalloproteinases
    Simon L. Parsons, Susan A. Watson, Peter de Nully Brown, Hilary M. Collins, Robert JC Steele · 1997 · British journal of surgery
15. Expression of full-length immunoglobulins in Escherichia coli: rapid and efficient production of aglycosylated antibodies
    Laura C. Simmons, Dorothea E. Reilly, Laura Klimowski, T. Shantha Raju, Gloria Meng, Paul W. Sims, Kyu Hong, Robert L. Shields, Lisa A. Damico, Patricia Rancatore et al. · 2002 · Journal of Immunological Methods
16. Targeting by affinity–matured recombinant antibody fragments of an angiogenesis associated fibronectin isoform
    Dario Neri, Barbara Carnemolla, Ahuva Nissim, Alessandra Leprini, Germano Querzé, Enrica Balza, Alessandro Pini, Lorenzo Tarli, Cornelia Halin, Paolo Neri et al. · 1997 · Nature Biotechnology
17. Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers
    Oliver Distler, Angela Del Rosso, Roberto Giacomelli, Paola Cipriani, Maria Letizia Conforti, Serena Guiducci, Renate E. Gay, Beat A. Michel, P Brühlmann, Ulf Müller‐Ladner et al. · 2002 · Arthritis Research & Therapy
18. Colorectal cancer: a review
    Juan José Granados-Romero, Alan Isaac Valderrama-Treviño, Ericka Hazzel Contreras-Flores, Baltazar Barrera‐Mera, Miguel Herrera Enríquez, Karen Uriarte-Ruíz, Jesús Carlos Ceballos-Villalva, Aranza Guadalupe Estrada-Mata, Cristopher Alvarado Rodríguez, Gerardo Arauz-Peña · 2017 · International Journal of Research in Medical Sciences
19. Vascular endothelial growth factor-dependent and -independent regulation of angiogenesis
    Masabumi Shibuya · 2008 · BMB Reports
20. Vascular endothelial growth factor in human glioma cell lines: induced secretion by EGF, PDGF-BB, and bFGF
    Jui‐Chang Tsai, Corey K. Goldman, G. Yancey Gillespie · 1995 · Journal of neurosurgery
21. Angiogenesis in Endocrine Tumors
    Helen E. Turner, Adrian Llewellyn Harris, Shlomo K. Melmed, John A. H. Wass · 2003 · Endocrine Reviews
22. Elevated γ-Aminobutyric Acid, Glutamate, and Vascular Endothelial Growth Factor Levels in the Vitreous of Patients With Proliferative Diabetic Retinopathy
    Jayakrishna Ambati · 1997 · Archives of Ophthalmology
23. Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer
    Kenneth John O'Byrne, Michael Ioannis Koukourakis, Alexandra N. Giatromanolaki, Giles Cox, Helen Turley, William P. Steward, Kevin C. Gatter, V Langrish · 2000 · British Journal of Cancer
24. Pamidronate induces modifications of circulating angiogenetic factors in cancer patients.
    Daniele Santini, Bruno Vincenzi, Giuseppe Avvisati, Giordano Dicuonzo, Fabrizio Battistoni, Michele Gavasci, Alfredo Salerno, Vincenzo Denaro, Giuseppe Tonini · 2002 · PubMed
25. Induction of Vascular Endothelial Growth Factor by Insulin-like Growth Factor 1 in Colorectal Carcinoma
    Robert S. Warren, Hui Yuan, Mary R. Matli, Napoleone Ferrara, David B. Donner · 1996 · Journal of Biological Chemistry
26. Involvement of the Transcription Factor NF-κB in Tubular Morphogenesis of Human Microvascular Endothelial Cells by Oxidative Stress
    Tadahisa Shono, Mayumi Ono, Hiroto Izumi, Sei‐ichiro Jimi, Kouji Matsushima, Takashi Okamoto, Kimitoshi Kohno, Michihiko Kuwano · 1996 · Molecular and Cellular Biology
27. Sphingosine 1‐phosphate released from platelets during clotting accounts for the potent endothelial cell chemotactic activity of blood serum and provides a novel link between hemostasis and angiogenesis
    Denis K. English, Zachary R. Welch, A. Thomas Kovala, Kevin A. Harvey, Olga V. Volpert, David N. Brindley, Joe G. N. Garcia · 2000 · The FASEB Journal
28. Vascular endothelial growth factor (VEGF)-like protein from orf virus NZ2 binds to VEGFR2 and neuropilin-1
    Lyn M. Wise, Tanja Veikkola, Andrew A. Mercer, Loreen J. Savory, Stephen B. Fleming, Carol Caesar, Angela A. Vitali, Taija Mäkinen, Kari K. Alitalo, Steven A. Stacker · 1999 · Proceedings of the National Academy of Sciences
29. Regulation of Angiogenesis by Hypoxia and Hypoxia‐Inducible Factors
    Michele M. Hickey, Marie Celeste Simon · 2006 · Current topics in developmental biology/Current Topics in Developmental Biology
30. The role of hyaluronan in tumour neovascularization (review)
    Paul Rooney, Shant Kumar, J. Ponting, Madeline Wang · 1995 · International Journal of Cancer
31. Comparative evaluation of the antitumor activity of antiangiogenic proteins delivered by gene transfer
    Calvin Jay Kuo, Filip A. Farnebo, Evan Y. Yu, Rolf H. B. Christofferson, Rebecca A. Swearingen, Robert Carter, Horst A. von Recum, Jenny Yuan, Junne Kamihara, Evelyn A. Flynn et al. · 2001 · Proceedings of the National Academy of Sciences
32. Vascular endothelial growth factor and endometriotic angiogenesis
    McLaren, J. · 2000 · Human Reproduction Update
33. Identification of functional estrogen response elements in the gene coding for the potent angiogenic factor vascular endothelial growth factor.
    Salman M. Hyder, Zafar Nawaz, Constance Chiappetta, George M. Stancel · 2000 · PubMed
34. High pre-treatment serum level of vascular endothelial growth factor (VEGF) is associated with poor outcome in small-cell lung cancer
    Petri Salvén, Tarja M. Ruotsalainen, Karin Mattson, Heikki Joensuu · 1998 · International Journal of Cancer
35. Clinical Experience with Angiogenesis Signaling Inhibitors: Focus on Vascular Endothelial Growth Factor (VEGF) Blockers
    Lee S. Rosen · 2002 · Cancer Control
36. MDM2 and Human Malignancies: Expression, Clinical Pathology, Prognostic Markers, and Implications for Chemotherapy
    Rayburn, Elizabeth, Zhang, Ruiwen, He, Jie, Wang, Hui · 2005 · Current Cancer Drug Targets
37. Vascular Endothelial Growth Factor Mediates Intracrine Survival in Human Breast Carcinoma Cells through Internally Expressed VEGFR1/FLT1
    Tae-Hee Lee, Seyha Seng, Masayuki Sekine, Cimona V. Hinton, Yigong Fu, Hava Karsenty Avraham, Shalom Avraham · 2007 · PLoS Medicine
38. ADAMTS1/METH1 Inhibits Endothelial Cell Proliferation by Direct Binding and Sequestration of VEGF165
    Alfonso Luque, Darren R. Carpizo, M. Luisa Iruela‐Arispe · 2003 · Journal of Biological Chemistry
39. Vascular endothelial growth factor (VEGF) and VEGF receptor inhibitors in the treatment of renal cell carcinomas
    Robert Jr. Roskoski · 2017 · Pharmacological Research
40. Mechanisms of angiogenesis and their use in the inhibition of tumor growth and metastasis
    Anne M. Saaristo, Terhi Kärpänen, Kari K. Alitalo · 2000 · Oncogene
41. VEGF and the Fab fragment of a humanized neutralizing antibody: crystal structure of the complex at 2.4 å resolution and mutational analysis of the interface
    Yves A. Muller, Yvonne Chen, Hans W. Christinger, Bing Li, Brian C. Cunningham, Henry B. Lowman, Abraham M. de Vos · 1998 · Structure
42. Molecular mechanism of VEGF and its role in pathological angiogenesis
    Ajmal Ahmad, Mohd Imtiaz Nawaz · 2022 · Journal of Cellular Biochemistry
43. Vascular Endothelial Growth Factor (VEGF), VEGF Receptors and Their Inhibitors for Antiangiogenic Tumor Therapy
    Satoru Takahashi · 2011 · Biological and Pharmaceutical Bulletin
44. Contribution of Tumor Endothelial Cells in Cancer Progression
    Kyoko Hida, Nako Maishi, Dorcas A. Annan, Yasuhiro Hida · 2018 · International Journal of Molecular Sciences
45. Manipulating Angiogenesis
    Michael Sean Pepper · 1997 · Arteriosclerosis Thrombosis and Vascular Biology
46. Angiogenesis Research: Guidelines for Translation to Clinical Application
    Timothy D. Browder, Jan E.W. Palmblad, Judah Folkman · 2001 · Thrombosis and Haemostasis
47. Preclinical Pharmacokinetics, Interspecies Scaling, and Tissue Distribution of a Humanized Monoclonal Antibody against Vascular Endothelial Growth Factor
    Yvonne S. Lin, Cindy B. Nguyen, Jose-Luis Mendoza, Enrique Escandón, David Fei, Y. Gloria Meng, Nishit B. Modi · 1999 · Journal of Pharmacology and Experimental Therapeutics
48. Vascular endothelial growth factor expression in primary esophageal squamous cell carcinoma
    Kimitoshi Inoue, Yuichi Ozeki, Toshiyuki Suganuma, Yoshiaki Sugiura, Susumu Tanaka · 1997 · Cancer
49. Vascular permeability factor gene expression in normal and neoplastic human ovaries.
    T. A. Olson, D Mohanraj, Linda F. Carson, Sundaram Ramakrishnan · 1994 · PubMed
50. Mechanisms of cancer metastasis
    María Castañeda, Petra den Hollander, Nick Allen Kuburich, Jeffrey M. Rosen, Sendurai A. Mani · 2022 · Seminars in Cancer Biology
51. Expression of angiostatin cDNA in a murine fibrosarcoma suppresses primary tumor growth and produces long-term dormancy of metastases.
    Ya Cao, M. OʼReilly, B Marshall, Evelyn A. Flynn, Richard W. Ji, Judah Folkman · 1998 · Journal of Clinical Investigation
52. Vascular Endothelial Growth Factor-A–Induced Chemotaxis of Monocytes Is Attenuated in Patients With Diabetes Mellitus
    Johannes L. Waltenberger, Juliane Lange, Andrea Kranz · 2000 · Circulation
53. Inhibition of tumor angiogenesis using a soluble receptor establishes a role for Tie2 in pathologic vascular growth.
    P Lin, Peter J. Polverini, Mark W. Dewhirst, S Shan, P S Rao, Kevin G. Peters · 1997 · Journal of Clinical Investigation
54. Tumor angiogenesis and anti-angiogenic therapy in malignant gliomas revisited
    Karl Heinz Plate, Alexander Scholz, Daniel Dumont · 2012 · Acta Neuropathologica
55. Cholesteryl Oligoarginine Delivering Vascular Endothelial Growth Factor siRNA Effectively Inhibits Tumor Growth in Colon Adenocarcinoma
    Won Jong Kim, Lane V. Christensen, Seongbong Jo, James William Yockman, Ji Hoon Jeong, Yong‐Hee Kim, Sung Wan Kim · 2006 · Molecular Therapy
56. The history of the angiogenic switch concept
    Doménico Ribatti, Beatrice Nico, Enrico Crivellato, Aldo Maria Roccaro, Angelo Vacca · 2006 · Leukemia
57. Binding to the Extracellular Matrix and Proteolytic Processing: Two Key Mechanisms Regulating Vascular Endothelial Growth Factor Action
    Napoleone Ferrara · 2010 · Molecular Biology of the Cell
58. Transforming growth factor‐α‐induced transcriptional activation of the vascular permeability factor (VPF/VEGF) gene requires AP‐2‐dependent DNA binding and transactivation
    Jens Gille, Robert A. Swerlick, S. Wright Caughman · 1997 · The EMBO Journal
59. Untitled work
    2003 · PubMed
60. Angiogenesis in Breast Cancer Progression, Diagnosis, and Treatment
    Chikezie O. Madu, Stephanie Y. Wang, Chinua O. Madu, Yi Wei Lu · 2020 · Journal of Cancer
61. A High Pretreatment Serum Vascular Endothelial Growth Factor Concentration Is Associated With Poor Outcome in Non-Hodgkin's Lymphoma
    Petri Salvén, Lasse M. Teerenhovi, Heikki Joensuu · 1997 · Blood
62. Vascular endothelial growth factor receptor-2 in breast cancer
    Shanchun Guo, Laronna S. Colbert, Miles H. Fuller, Yuanyuan Zhang, Ruben Rene Gonzalez-Perez · 2010 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
63. Phase I Trial and Pharmacokinetic Study of Bevacizumab in Pediatric Patients With Refractory Solid Tumors: A Children's Oncology Group Study
    Julia Glade Bender, Peter C. Adamson, Joel M. Reid, Lu Xu, Sylvain Baruchel, Yuval Shaked, Robert S. Kerbel, Erin Cooney, Diana Stempak, Helen X. Chen et al. · 2008 · Journal of Clinical Oncology
64. Neutralizing anti-vascular endothelial growth factor antibody completely inhibits angiogenesis and growth of human prostate carcinoma micro tumors in vivo
    Per Borgström, Mario A. Bourdon, Kenneth J. Hillan, P. Sriramarao, Napoleone Ferrara · 1998 · The Prostate
65. Proinflammatory functions of vascular endothelial growth factor in alloimmunity
    Reinders, Marlies E.J., Sho, Masayuki, Izawa, Atsushi, Wang, Ping, Mukhopadhyay, Debabrata, Koss, Kerith E., Geehan, Christopher S., Luster, Andrew D., Sayegh, Mohamed H., Briscoe, David M. · 2003 · Journal of Clinical Investigation
66. Complete inhibition of rhabdomyosarcoma xenograft growth and neovascularization requires blockade of both tumor and host vascular endothelial growth factor.
    Hans‐Peter Gerber, Joe Kowalski, Daniel A. Sherman, David A. Eberhard, Napoleone Ferrara · 2000 · PubMed
67. Targeting pericytes for therapeutic approaches to neurological disorders
    Jinping Cheng, Nils Korte, Ross Nortley, Huma Sethi, Yamei Tang, David Attwell · 2018 · Acta Neuropathologica
68. Anti-VEGF therapies in the clinic
    Meadows, K. L., Hurwitz, H. I. · 2012 · Cold Spring Harbor Perspectives in Medicine
69. Upregulation of Interleukin 8 by Oxygen-deprived Cells in Glioblastoma Suggests a Role in Leukocyte Activation, Chemotaxis, and Angiogenesis
    Isabelle Desbaillets, Annie‐Claire Diserens, Nicolas de Tribolet, Marie‐France Hamou, Erwin G. Van Meir · 1997 · The Journal of Experimental Medicine
70. Urokinase receptor antagonists inhibit angiogenesis and primary tumor growth in syngeneic mice.
    H Y Min, Laura V. Doyle, Charles R. Vitt, Catherine Zandonella, Jennifer R. Stratton-Thomas, Marc A. Shuman, S Rosenberg · 1996 · PubMed
71. VEGF in Brain Tumors
    Márcia Regina Machein, Karl Heinz Plate · 2000 · Journal of Neuro-Oncology
72. A mesoporous silica nanoparticle – PEI – Fusogenic peptide system for siRNA delivery in cancer therapy
    Li Xu, Yijie Chen, Mingqi Wang, Yongjie Ma, Weiliang Xia, Hongchen Gu · 2012 · Biomaterials
73. Angiostatin gene transfer: Inhibition of tumor growth in vivo by blockage of endothelial cell proliferation associated with a mitosis arrest
    Frank Griscelli, Hong Li, Annelise Bennaceur Griscelli, J. Soria, Paule Opolon, Claudine Soria, Michel Perricaudet, Patrice Yeh, Lu H · 1998 · Proceedings of the National Academy of Sciences
74. Targeting VEGF-A to Treat Cancer and Age-Related Macular Degeneration
    Napoleone Ferrara, ROBERT D. MASS, Claudio Campa, Robert Kim · 2006 · Annual Review of Medicine
75. Molecular angiogenesis
    Michael Klagsbrun, Marsha A. Moses · 1999 · Chemistry & Biology
76. Control of tumour vascular permeability
    Dilair F. Baban, Leonard William Seymour · 1998 · Advanced Drug Delivery Reviews
77. Vascular endothelial growth factor and vascular adjustments to perturbations in oxygen homeostasis
    Yuval Dor, Rinnat M. Porat, Eli Keshet · 2001 · American Journal of Physiology-Cell Physiology
78. Possible Mechanisms of Acquired Resistance to Anti-angiogenic Drugs: Implications for the Use of Combination Therapy Approaches
    Robert S. Kerbel, Joanne Yu, Jennifer Tran, Shan Man, Alicia Viloria‐Petit, Giannoula Lakka Klement, Brenda Lynn Coomber, Janusz W. Rak · 2001 · Cancer and Metastasis Reviews
79. The crystal structure of vascular endothelial growth factor (VEGF) refined to 1.93 Å resolution: multiple copy flexibility and receptor binding
    Yves A. Muller, Hans W. Christinger, Bruce A. Keyt, Abraham M. de Vos · 1997 · Structure
80. Involvement of vascular endothelial growth factor receptor-3 in maintenance of integrity of endothelial cell lining during tumor angiogenesis
    Hajime Kubo, Takashi Fujiwara, Lotta Jussila, Hiroyuki Hashi, Minetaro Ogawa, Kenji Shimizu, Masaaki Awane, Yoshiharu Sakai, Arimichi Takabayashi, Kari K. Alitalo et al. · 2000 · Blood
81. Oncogenes as inducers of tumor angiogenesis
    Janusz W. Rak, Jorge Filmus, Günter Finkenzeller, Stefan Grugel, Dieter Marm�, Robert S. Kerbel · 1995 · Cancer and Metastasis Reviews
82. Simultaneous elevation in the serum concentrations of the angiogenic growth factors VEGF and bFGF is an independent predictor of poor prognosis in non-Hodgkin lymphoma: a single-institution study of 200 patients
    Petri Salvén, Arto Orpana, Lasse M. Teerenhovi, Heikki Joensuu · 2000 · Blood
83. Immunotherapy of tumors with xenogeneic endothelial cells as a vaccine
    Yu-quan Wei, Qing-ru Wang, Xia Zhao, Yang Li, Ling Tian, You Lü, Bin Kang, Chong-jiu Lu, Mei-juan Huang, Yanyan Lou et al. · 2000 · Nature Medicine
84. Quantitation and physiological characterization of angiogenic vessels in mice: effect of basic fibroblast growth factor, vascular endothelial growth factor/vascular permeability factor, and host microenvironment.
    Marc Dellian, Brian P. Witwer, Hassan A. Salehi, Fan Yuan, R K Jain · 1996 · Europe PMC (PubMed Central)
85. Molecular cloning, sequencing and expression of the mRNA encoding human Cdx1 and Cdx2 homeobox. Down-regulation of Cdx1 and Cdx2 mRNA expression during colorectal carcinogenesis
    Gustavo V. Mallo, Hocine Rechreche, Jean-Marc Frigerio, Dominique Rocha, Alain Zweibaum, Michel Lacasa, Bertrand Jordan, Nelson Dusetti, Jean–Charles Dagorn, Juan Iovanna · 1997 · International Journal of Cancer
86. Resveratrol and quercetin inhibit angiogenesis in vitro
    Koichi Igura, Toshiro Ohta, Yukiaki Kuroda, Kazuhiko Kaji · 2001 · Cancer Letters
87. Matrix metalloproteinases
    Simon L. Parsons, Susan A. Watson, Peter de Nully Brown, Hilary M. Collins, Robert JC Steele · 1997 · British journal of surgery
88. Regression of established tumors and metastases by potent vascular endothelial growth factor blockade
    Jianzhong Huang, Jason S. Frischer, Anna Serur, Angela Kadenhe, Akiko Yokoi, Kimberly W. McCrudden, Tamara N. New, Kathleen O’Toole, Stephanie M. Zabski, John S. Rudge et al. · 2003 · Proceedings of the National Academy of Sciences
89. Endogenous angiogenesis inhibitors and their therapeutic implications
    Yumei Cao · 2001 · The International Journal of Biochemistry & Cell Biology
90. Tumor-derived expression of vascular endothelial growth factor is a critical factor in tumor expansion and vascular function.
    Jeremy Grunstein, Walter Gregory Roberts, Odile A. Mathieu-Costello, Douglas Hanahan, Randall S. Johnson · 1999 · PubMed
91. Microvessel count and cerebrospinal fluid basic fibroblast growth factor in children with brain tumours
    V.W Li, Channing Yu, Judah Folkman, R. Michael Scott, Peter McL. Black, Rebecca Dunn Folkerth, Patrick D. Barnes, Stephen E. Sallan, Maria Ann Rupnick, Hiroyuki Watanabe · 1994 · The Lancet
92. VEGF165b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy
    Alexander H. R. Varey, E S Rennel, Yan Qiu, Heather S. Bevan, R. M. Perrin, S Raffy, AR Dixon, C Paraskeva, O Zaccheo, Andrew Bassim Hassan et al. · 2008 · British Journal of Cancer
93. Molecular Mechanisms of Developmental and Tumor Angiogenesis
    Karl Heinz Plate, Georg Breier, Werner Risau · 1994 · Brain Pathology
94. A Peptoid “Antibody Surrogate” That Antagonizes VEGF Receptor 2 Activity
    D. Gomika Udugamasooriya, Sean Patrick Dineen, Rolf A. Brekken, Thomas J. Kodadek · 2008 · Journal of the American Chemical Society
95. Therapeutic Inhibition of VEGF Signaling and Associated Nephrotoxicities
    Chelsea C. Estrada, Alejandro Maldonado, Sandeep K. Mallipattu · 2019 · Journal of the American Society of Nephrology
96. Outcomes after Intravitreal Bevacizumab versus Laser Photocoagulation for Retinopathy of Prematurity
    Christopher K. Hwang, G. Baker Hubbard, Amy K. Hutchinson, Scott R. Lambert · 2015 · Ophthalmology
97. Invasion and metastasis in pancreatic cancer.
    Shereen Keleg, Peter Büchler, Roman Ludwig, Markus Wolfgang Büchler, Helmut Frieß · 2003 · Molecular Cancer
98. Oncogenes and Angiogenesis: Signaling Three-Dimensional Tumor Growth
    Janusz W. Rak, Joanne Yu, Giannoula Lakka Klement, Robert S. Kerbel · 2000 · Journal of Investigative Dermatology Symposium Proceedings
99. Inhibition of vascular endothelial growth factor with a sequence-specific hypoxia response element antagonist
    Olenyuk, Bogdan Z., Zhang, Guo-Jun, Klco, Jeffery M., Nickols, Nicholas G., Kaelin, William G., Dervan, Peter B. · 2004 · Proceedings of the National Academy of Sciences
100. Inhibition of human cancer cell line growth and human umbilical vein endothelial cell angiogenesis by artemisinin derivatives in vitro
     Haiyong Chen · 2003 · Pharmacological Research